Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
HSI Professor Joseph Doyle is interviewed on Freakomomics, M.D. podcast
Economist Anna Stansbury is joining MIT Sloan’s Work and Organization Studies Group as an Assistant Professor this September, and she will also be part of the faculty of the MIT Institute for Work and Employment Research (IWER).
Read the Spring 2023 newsletter of the MIT Institute for Work and Employment Research
By
If U.S. workers could select the characteristics of a labor organization to represent them, what would they choose? That’s the question explored in an intriguing new journal article by Alexander Hertel-Fernandez of Columbia University’s School of International and Public Affairs, William Kimball of ...
By
MIT Sloan Adjunct Professor Mary P. Rowe, a pioneer in the organizational ombuds profession, has made many of the articles she has written over her career freely available on her personal webpages at MIT Sloan.
Members of the Student Sloan Healthcare Club are always responsible for this conference, but this year, the 19th, presented new complications since the event was held entirely online.
By
A panel of practitioners explores how to solve worker shortages and offers three best practices for success.
